MiNK Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.653; its P/E ratio is -1.34; MiNK Therapeutics is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -5.67M	$ -5.22M	$ -6.34M	$ -5.69M	$ -7.90M
EBITDA	$ -5.61M	$ -5.17M	-	$ -5.64M	$ -7.87M
Net Income Common Stockholders	$ -5.46M	$ -5.12M	$ -6.20M	$ -5.69M	$ -7.77M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 3.40M	$ 6.40M	$ 10.60M	$ 14.90M	$ 19.60M
Total Assets	$ 4.55M	$ 7.46M	$ 12.09M	$ 16.60M	$ 21.47M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -3.40M	$ -6.40M	$ -10.60M	$ -14.90M	$ -19.60M
Total Liabilities	$ 22.61M	$ 21.04M	$ 21.61M	$ 21.06M	$ 21.87M
Stockholders Equity	$ -18.06M	$ -13.58M	$ -9.47M	$ -4.45M	$ -401.30K
Cash Flow	-
Free Cash Flow	$ -3.04M	$ -4.23M	-	$ -4.38M	$ -4.56M
Operating Cash Flow	$ -3.04M	$ -4.21M	-	$ -4.37M	$ -4.43M
Investing Cash Flow	-	$ -23.04K	-	$ -13.50K	$ -127.84K
Financing Cash Flow	$ -2.00	$ 2.95K	-	$ -334.43K	$ 111.00

Currency in USD

MiNK Therapeutics Earnings and Revenue History

Income Statement >

MiNK Therapeutics Debt to Assets

Balance Sheet >

MiNK Therapeutics Cash Flow

Cash Flow >

MiNK Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing